Clinical and pharmacological profile of benznidazole for treatment of Chagas disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical and pharmacological profile of benznidazole for treatment of Chagas disease
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume -, Issue -, Pages 1-15
Publisher
Informa UK Limited
Online
2018-08-16
DOI
10.1080/17512433.2018.1509704
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial
- (2018) Victor Kande Betu Ku Mesu et al. LANCET
- Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial
- (2018) Faustino Torrico et al. LANCET INFECTIOUS DISEASES
- Benznidazole treatment safety: the Médecins Sans Frontières experience in a large cohort of Bolivian patients with Chagas' disease
- (2017) Gilberto Marcelo Sperandio da Silva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Treatment of Infected Women of Childbearing Age Prevents Congenital Trypanosoma cruzi Infection by Eliminating the Parasitemia Detected by PCR
- (2017) Laura Murcia et al. JOURNAL OF INFECTIOUS DISEASES
- Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers
- (2017) Carlos A. Morillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease
- (2017) Mario J. Olivera et al. PLoS One
- Benznidazole, the trypanocidal drug used for Chagas disease, induces hepatic NRF2 activation and attenuates the inflammatory response in a murine model of sepsis
- (2017) Flavia Lambertucci et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole
- (2017) Mônica C. Campos et al. Scientific Reports
- How universal is coverage and access to diagnosis and treatment for Chagas disease in Colombia? A health systems analysis
- (2017) Zulma M. Cucunubá et al. SOCIAL SCIENCE & MEDICINE
- Improving access to Chagas disease diagnosis and etiologic treatment in remote rural communities of the Argentine Chaco through strengthened primary health care and broad social participation
- (2017) Paula Sartor et al. PLoS Neglected Tropical Diseases
- A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: The Bolivian Chagas Platform
- (2017) Maria-Jesus Pinazo et al. PLoS Neglected Tropical Diseases
- Chagas cardiomyopathy: The potential effect of benznidazole treatment on diastolic dysfunction and cardiac damage in dogs chronically infected with Trypanosoma cruzi
- (2016) Fabiane M. Santos et al. ACTA TROPICA
- Up-regulation of ATP-binding cassette transporters in the THP-1 human macrophage cell line by the antichagasic benznidazole
- (2016) Virginia G Perdomo et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- 2 nd Brazilian Consensus on Chagas Disease, 2015
- (2016) João Carlos Pinto Dias et al. Revista da Sociedade Brasileira de Medicina Tropical
- Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study
- (2016) Lisandro D. Colantonio et al. PLoS Neglected Tropical Diseases
- Estimating the Burden of Chagas Disease in the United States
- (2016) Jennifer Manne-Goehler et al. PLoS Neglected Tropical Diseases
- The BENEFIT Trial: Where Do We Go from Here?
- (2016) Bernard Pecoul et al. PLoS Neglected Tropical Diseases
- Evaluation of Parasiticide Treatment with Benznidazol in the Electrocardiographic, Clinical, and Serological Evolution of Chagas Disease
- (2016) Abilio Augusto Fragata-Filho et al. PLoS Neglected Tropical Diseases
- Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage
- (2016) Amanda Fortes Francisco et al. Scientific Reports
- Access to Care for Chagas Disease in the United States: A Health Systems Analysis
- (2015) Jennifer Manne-Goehler et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Population Pharmacokinetics of Benznidazole in Adult Patients with Chagas Disease
- (2015) D. Soy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult Patients
- (2015) María Gabriela Álvarez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prevention of congenital Chagas through treatment of girls and women of childbearing age
- (2015) Guillermo Moscatelli et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Integrated control of Chagas disease for its elimination as public health problem - A Review
- (2015) Sergio Sosa-Estani et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole
- (2015) Bianca Zingales et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy
- (2015) Carlos A. Morillo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Translational challenges of animal models in Chagas disease drug development: a review
- (2015) Eric Chatelain et al. Drug Design Development and Therapy
- Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies
- (2015) Yanina Sguassero et al. PLoS One
- Chagas Disease Awareness Among Latin American Immigrants Living in Los Angeles, California
- (2014) Daniel R. Sanchez et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Antitrypanosomal Activity of Fexinidazole Metabolites, Potential New Drug Candidates for Chagas Disease
- (2014) Maria T. Bahia et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Limited infant exposure to benznidazole through breast milk during maternal treatment for Chagas disease
- (2014) Facundo García-Bournissen et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review
- (2014) Maria-Jesús Pinazo et al. Expert Review of Anti-Infective Therapy
- Benznidazole-resistance in Trypanosoma cruzi: Evidence that distinct mechanisms can act in concert
- (2014) Mônica C.O. Campos et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
- (2014) Israel Molina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic responses to different anti-Trypanosoma cruzi drugs in experimental infection by benznidazole-resistant parasite stock
- (2014) SÉRGIO CALDAS et al. PARASITOLOGY
- Uneventful benznidazole treatment of acute Chagas disease during pregnancy: a case report
- (2014) Valeria Rita Corrêa et al. Revista da Sociedade Brasileira de Medicina Tropical
- Evaluation of compliance to congenital Chagas disease treatment: results of a randomised trial in Bolivia
- (2014) J.-P. Chippaux et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects
- (2014) Stephen Patterson et al. TRENDS IN PARASITOLOGY
- Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development
- (2014) Carolina B. Moraes et al. Scientific Reports
- Trypanocide Treatment of Women Infected with Trypanosoma cruzi and Its Effect on Preventing Congenital Chagas
- (2014) Diana L. Fabbro et al. PLoS Neglected Tropical Diseases
- Benznidazole Biotransformation and Multiple Targets in Trypanosoma cruzi Revealed by Metabolomics
- (2014) Andrea Trochine et al. PLoS Neglected Tropical Diseases
- Towards a Paradigm Shift in the Treatment of Chronic Chagas Disease
- (2013) R. Viotti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New, Combined, and Reduced Dosing Treatment Protocols Cure Trypanosoma cruzi Infection in Mice
- (2013) J. M. Bustamante et al. JOURNAL OF INFECTIOUS DISEASES
- Global economic burden of Chagas disease: a computational simulation model
- (2013) Bruce Y Lee et al. LANCET INFECTIOUS DISEASES
- P-glycoprotein efflux pump plays an important role in Trypanosoma cruzi drug resistance
- (2013) Mônica Caroline Oliveira Campos et al. PARASITOLOGY RESEARCH
- Achievements and Challenges upon the Implementation of a Program for National Control of Congenital Chagas in Bolivia: Results 2004–2009
- (2013) Cristina Alonso-Vega et al. PLoS Neglected Tropical Diseases
- Barriers to Treatment Access for Chagas Disease in Mexico
- (2013) Jennifer M. Manne et al. PLoS Neglected Tropical Diseases
- Benznidazole-Related Adverse Drug Reactions and Their Relationship to Serum Drug Concentrations in Patients with Chronic Chagas Disease
- (2012) María-Jesús Pinazo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cardiomyopathy prognosis after benznidazole treatment in chronic canine Chagas' disease
- (2012) F. M. Santos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vivosusceptibility to benznidazole ofTrypanosoma cruzistrains from the western Brazilian Amazon
- (2012) Ana P. M. Teston et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Fexinidazole: A Potential New Drug Candidate for Chagas Disease
- (2012) Maria Terezinha Bahia et al. PLoS Neglected Tropical Diseases
- Trypanocidal Activity of Nitroaromatic Prodrugs: Current Treatments and Future Perspectives
- (2011) Shane R. Wilkinson et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Congenital Chagas Disease: Recommendations for Diagnosis, Treatment and Control of Newborns, Siblings and Pregnant Women
- (2011) Yves Carlier et al. PLoS Neglected Tropical Diseases
- Effects of Ravuconazole Treatment on Parasite Load and Immune Response in Dogs Experimentally Infected with Trypanosoma cruzi
- (2010) L. d. F. Diniz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease
- (2010) Margoth Moreno et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Adverse Events After the Use of Benznidazole in Infants and Children With Chagas Disease
- (2010) J. Altcheh et al. PEDIATRICS
- Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission
- (2010) Sergio Sosa-Estani et al. Revista da Sociedade Brasileira de Medicina Tropical
- In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds
- (2010) Adriana M. C. Canavaci et al. PLoS Neglected Tropical Diseases
- Trypanocidal drugs: mechanisms, resistance and new targets
- (2009) Shane R. Wilkinson et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina
- (2009) Sergio Sosa-Estani et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Feasibility, Drug Safety, and Effectiveness of Etiological Treatment Programs for Chagas Disease in Honduras, Guatemala, and Bolivia: 10-Year Experience of Médecins Sans Frontières
- (2009) Oliver Yun et al. PLoS Neglected Tropical Diseases
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started